Arxis (ARXS) – Research Analysts’ Recent Ratings Updates

Several brokerages have updated their recommendations and price targets on shares of Arxis (NASDAQ: ARXS) in the last few weeks:

• 6/2/2026 – Arxis had its price target raised by Citigroup Inc. from $42.00 to $50.00. They now have a “buy” rating on the stock.
• 6/1/2026 – Arxis had its price target raised by Wells Fargo & Company from $42.00 to $52.00. They now have an “overweight” rating on the stock.
• 6/1/2026 – Arxis had its price target raised by Morgan Stanley from $44.00 to $50.00. They now have an “overweight” rating on the stock.
• 5/31/2026 – Arxis had its “buy” rating reaffirmed by Jefferies Financial Group Inc.. They now have a $55.00 price target on the stock.
• 5/29/2026 – Arxis had its price target raised by Royal Bank Of Canada from $39.00 to $46.00. They now have a “sector perform” rating on the stock.
• 5/12/2026 – Arxis was upgraded by Zacks Research to “hold”.
• 5/11/2026 – Arxis is now covered by Wells Fargo & Company. They set an “overweight” rating and a $42.00 price target on the stock.
• 5/11/2026 – Arxis is now covered by Jefferies Financial Group Inc.. They set a “buy” rating and a $42.00 price target on the stock.
• 5/11/2026 – Arxis is now covered by Citigroup Inc.. They set a “buy” rating and a $42.00 price target on the stock.
• 5/11/2026 – Arxis is now covered by Wolfe Research. They set an “outperform” rating and a $43.00 price target on the stock.
• 5/11/2026 – Arxis is now covered by Royal Bank Of Canada. They set a “sector perform” rating and a $39.00 price target on the stock.
• 5/11/2026 – Arxis is now covered by William Blair. They set an “outperform” rating on the stock.
• 5/11/2026 – Arxis is now covered by Morgan Stanley. They set an “overweight” rating and a $44.00 price target on the stock.
• 5/11/2026 – Arxis is now covered by Rothschild & Co Redburn. They set a “buy” rating and a $40.00 price target on the stock.
• 5/11/2026 – Arxis is now covered by Robert W. Baird. They set an “outperform” rating and a $55.00 price target on the stock.
• 5/11/2026 – Arxis was given a new $53.00 price target by UBS Group AG.
• 5/11/2026 – Arxis is now covered by The Goldman Sachs Group, Inc.. They set a “buy” rating and a $53.00 price target on the stock.
• 5/11/2026 – Arxis is now covered by Wolfe Research. They set an “outperform” rating and a $43.00 price target on the stock.
• 5/11/2026 – Arxis is now covered by Wells Fargo & Company. They set an “overweight” rating and a $42.00 price target on the stock.
• 5/11/2026 – Arxis is now covered by Royal Bank Of Canada. They set a “hold” rating and a $39.00 price target on the stock.
• 5/11/2026 – Arxis is now covered by Jefferies Financial Group Inc.. They set a “buy” rating and a $42.00 price target on the stock.
• 5/11/2026 – Arxis is now covered by The Goldman Sachs Group, Inc.. They set a “buy” rating and a $53.00 price target on the stock.
• 5/11/2026 – Arxis is now covered by Robert W. Baird. They set an “outperform” rating and a $55.00 price target on the stock.
• 5/11/2026 – Arxis is now covered by Melius Research. They set a “buy” rating and a $45.00 price target on the stock.
• 5/2/2026 – Arxis was upgraded by Wall Street Zen to “hold”.

Insider Transactions at Arxis

In other Arxis news, Director Stephen Duane Oetgen acquired 25,000 shares of the business’s stock in a transaction on Friday, April 17th. The stock was purchased at an average price of $28.00 per share, for a total transaction of $700,000.00. Following the transaction, the director owned 30,357 shares in the company, valued at $849,996. This trade represents a 466.68% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Azad Sid Badakhsh acquired 36,000 shares of the business’s stock in a transaction on Friday, April 17th. The stock was acquired at an average price of $28.00 per share, with a total value of $1,008,000.00. Following the transaction, the insider owned 403,864 shares in the company, valued at approximately $11,308,192. The trade was a 9.79% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last quarter, insiders have purchased 201,564 shares of company stock worth $5,643,792.

We are a leading designer and manufacturer of proprietary, mission-critical electronic and mechanical components engineered for cutting-edge performance in extreme environments. Leveraging significant intellectual property (“IP”) and world-class engineering capabilities, we design and deliver innovative solutions that address some of our customers’ most complex performance needs. Arxis is the result of a deliberate and disciplined strategy executed by our sponsor, Arcline, and the Arxis management team to create a purpose-built, cohesive business through targeted acquisitions with similar product and end market characteristics.